Article

Safety and Efficacy Conerns in the Use of Intravitreal Anti-VEGF Therapy (Sponsored)

This supplement to Ophthalmology Times is sponsored by CME Matters, LLC, and supported by an unrestricted grant from Regeneron Pharmaceuticals, Inc.

 

Safety and Efficacy Conerns in the
Use of Intravitreal Anti-VEGF Therapy

The Historical Perspective on
Efficacy and Systemic Safety


This supplement to Ophthalmology Times is sponsored by CME Matters, LLC, and supported by an unrestricted grant from Regeneron Pharmaceuticals, Inc.
 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI Myopia Workshop: Michael X. Repka, MD, MBA, on building consensus and future directions
(Image credit: Ophthalmology Times) Introducing iOpeners: Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
© 2025 MJH Life Sciences

All rights reserved.